PositiveID Corporation (fka PSID)

[greaseyfingers]

Your perceived PSID opinion-viewpoint appears to be correct..IMO

greaseyfingers Saturday, March 09, 2013 5:03:16 AM
Re: steltz02 post# 6792 Post #6793 of 6826
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85487044

I don't-think PSID-is-close to being-a done-deal, yet, either..IMO

Awarding of a Phase II, Stage 1 Contract Continuation will be decided upon by the outcome of a Gen-3 Analysis of Alternatives, (AoA), which was initiated by the Department of Homeland Security in July 2012, as part of the Official Required Procedure..IMO

A decision on the BioWatch Gen-3 program which is projected to be announced in the fall of 2013, following the completion of the Gen-3 Analysis of Alternatives, AoA..

Depending if this required Gen-3 Analysis of Alternatives, (AoA), decision, projected to be announced in the fall of 2013, results in a favorable, or unfavorable decision status, will determine the fate of the BioWatch Gen-3 program..IMO

This Analysis of Alternatives, (AoA), decision could end the BioWatch Gen-3 program, or delay it, or give it the green light to contiue on to the next step, Phase II, Stage 1 Contract for the scheduled 18 months of Performance Testing..IMO ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Official Information from the Government's Website..

BioWatch Gen-3 Phase II, Stage 1 Presolicitation and Draft Request for Proposal

Solicitation Number: HSHQDC-13-R-00026
Agency: Department of Homeland Security
Office: Office of the Chief Procurement Officer
Location: Office of Procurement Operations

Changed
Feb 08, 2013
1:35 pm

Solicitation Number:
HSHQDC-13-R-00026 Notice Type:

Modification/Amendment Synopsis:
Added: Feb 08, 2013 1:35 pm

The purpose of this update is to inform interested parties that posting of the draft RFP does not represent a commitment by the Government to release a final RFP or to award a contract.

The draft RFP is posted for purposes of obtaining industry comments and feedback on the proposed solicitation approach for fulfilling Phase II, Stage 1 requirements.

Award of a Phase II, Stage 1 contract will be subject to the outcome of a Gen-3 Analysis of Alternatives (AoA) initiated by the Department of Homeland Security in July 2012.

A decision on the Gen-3 program is projected in the fall of 2013 following completion of the Analysis of Alternatives, (AoA).

Please continue to monitor FedBizOpps for additional updates.

Contracting Office Address:
Office of the Chief Procurement Officer
Washington, District of Columbia 20528
United States

Place of Performance:
Continental United States

United States

Primary Point of Contact.:
Carla Davis,
Contracting Officer
[e-mail]

https://www.fbo.gov/index?id=90399125fc575caa7b316dce773b1192
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

BioWatch Gen-3 Phase II, Stage1 Presolicitation and Draft Request for Proposal

Solicitation Number: HSHQDC-13-R-00026
Agency: Department of Homeland Security
Office: Office of the Chief Procurement Officer
Location: Office of Procurement Operations

Solicitation Number: HSHQDC-13-R-00026

Notice Type: Presolicitation

C.1.2. TWO STAGE PROCUREMENT

DHS plans to conduct a two-stage procurement for the Gen-3 Phase II acquisition using a competitive down-selection technique between stages.

Stage 1 will be for Performance Testing of candidate systems and

Stage 2 will be for Operational Test and Evaluation (OT&E), Detector Production, Deployment, Sustainment and Disposal.

The Government anticipates awarding multiple contracts for Stage 1.

However, only one contract will be awarded under Stage 2 after a competive down selection between stages.

At the conclusion of Stage 1 a separate solicitation will be issued for Stage 2 requirements.

Stage 2 will be a full and open competition.

As in Stage 1, Stage 2 offerors must also demonstrate a design maturity equivalent to that of Technology Readiness Level 7, or greater, as described in Section C.2.5. below.

In addition, they must provide an equivalent third-party data set as was generated during Stage 1.

DRAFT Request for Proposal: HSHQDC-13-R-00026
Type: Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Posted Date: January 25, 2013

HSHQDC-13-R-00026_COVER_LETTER.pdf (132.85 Kb)
Description: Cover Letter: DRAFT Request for Proposal, HSHQDC-13-R-00026

HSHQDC-13-R-00026_DRAFT_RFP,_BioWatch_Gen-3_Phase_2_... (588.76 Kb)Download/View
HSHQDC-13-R-00026_DRAFT_RFP,_BioWatch_Gen3_Phase_2_Stage_1.pdfDescription: DRAFT Request for Proposal,

HSHQDC-13-R-00026 J.1_Cost_Pricing_Schedule.xls (35.50 Kb)
Description: ATTACHMENT J.1: Cost/Pricing Schedule

J.6_Question_and_Answer_Sheet.xlsx (11.64 Kb)
Description: ATTACHMENT J.6: Draft RFP Question and Answer Sheet

J.8_NonDisclosure_Agreement.pdf (32.19 Kb)
Description: ATTACHMENT J.8: BioWatch Non-Disclosure Agreement

J.10...Subcontracting_Plan_Checklist.pdf (632.32 Kb)
Description: ATTACHMENT J.10: Small Business Subcontracting Plan Checklist

Contracting Office Address:
Office of the Chief Procurement Officer
Washington, District of Columbia 20528
United States

Place of Performance:
Continental United States

https://www.fbo.gov/index?s=opportunity&mode=form&id=cd3f4aa9250b9d0e77118d4d5693c2a1&tab=core&_cview=0
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~